Latest Transplant rejection Stories
Kidney transplant recipients who develop antibodies in response to receiving new organs can develop accelerated arteriosclerosis, or narrowing of the arteries that supply blood to the kidney.
For the first time, scientists at Toronto General Hospital, University Health Network have shown in a clinical trial that the Toronto XVIVO System can safely and effectively treat, re-assess and improve the function of high-risk donor lungs so that they can be successfully transplanted into patients.
SAN DIEGO, April 13, 2011 /PRNewswire/ -- The engineering of replacement tissue shows promise to dramatically impact the treatment of patients with end stage heart failure.
EXTON, Pa., March 29, 2011 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced initiation of a Phase 2 clinical study to evaluate the safety and efficacy of C1 Esterase Inhibitor [Human] for the treatment of acute antibody-mediated rejection (AMR) in recipients of donor-specific cross-match positive kidney transplants.
Lung transplant patients have double the risk of organ rejection and death within five years of the procedure if they live near a main road.
A transplant patient in New York has contracted the AIDS virus from the kidney of a living donor, the nation's first case of transmission from a living organ donor since screening for HIV began in the mid-1980s, the New York State Department of Health said on Thursday.
Sirolimus, a drug currently used to help prevent transplant rejection, can improve lung function and quality of life in individuals living with the lung disease lymphangioleiomyomatosis (LAM).
Test monitors level of a drug that helps prevent kidney rejection SILVER SPRING, Md., Feb. 11, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced that it has cleared a test to help manage potential organ rejection in kidney transplant patients.
SAN FRANCISCO, Jan.
UCSF researchers have tackled a decade-long scientific conundrum, and their discovery is expected to lead to significant advances in using stem cells to treat genetic diseases before birth.